Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Provost

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Vaccine|August 1, 1995
Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study GroupB J Kuter, A Ngai, C M Patterson, et al.
The Journal of Infectious Diseases|July 1, 1997
Immunoprecipitation and virus neutralization assays demonstrate qualitative differences between protective antibody responses to inactivated hepatitis A vaccine and passive immunization with immune globulinS M Lemon, P C Murphy, P J Provost, et al.
Bulletin of the Pan American Health Organization|January 1, 1977
Infectious hepatitis (hepatitis A) research in nonhuman primatesM R Hilleman, P J Provost, V M Villarejos, et al.
Journal of Hepatology|January 1, 1993
Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326FM E Armstrong, P A Giesa, J P Davide, et al.
Vaccine|February 1, 1991
Antibody assays suitable for assessing immune responses to live varicella vaccineP J Provost, D L Krah, B J Kuter, et al.
The Pediatric Infectious Disease Journal|January 1, 1992
Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody responseC J White, B J Kuter, A Ngai, et al.
Pediatrics|May 1, 1991
Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989C J White, B J Kuter, C S Hildebrand, et al.
Vaccine|September 1, 1991
Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studiesB J Kuter, R E Weibel, H A Guess, et al.
Journal of Virology|October 1, 1987
Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virusP J Provost, P M Keller, F S Banker, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Vaccine|August 1, 1995
Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study GroupB J Kuter, A Ngai, C M Patterson, et al.
The Journal of Infectious Diseases|July 1, 1997
Immunoprecipitation and virus neutralization assays demonstrate qualitative differences between protective antibody responses to inactivated hepatitis A vaccine and passive immunization with immune globulinS M Lemon, P C Murphy, P J Provost, et al.
Bulletin of the Pan American Health Organization|January 1, 1977
Infectious hepatitis (hepatitis A) research in nonhuman primatesM R Hilleman, P J Provost, V M Villarejos, et al.
Journal of Hepatology|January 1, 1993
Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326FM E Armstrong, P A Giesa, J P Davide, et al.
Vaccine|February 1, 1991
Antibody assays suitable for assessing immune responses to live varicella vaccineP J Provost, D L Krah, B J Kuter, et al.
The Pediatric Infectious Disease Journal|January 1, 1992
Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody responseC J White, B J Kuter, A Ngai, et al.
Pediatrics|May 1, 1991
Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989C J White, B J Kuter, C S Hildebrand, et al.
Vaccine|September 1, 1991
Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studiesB J Kuter, R E Weibel, H A Guess, et al.
Journal of Virology|October 1, 1987
Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virusP J Provost, P M Keller, F S Banker, et al.
Pageof 4